- $238.55m
- $220.66m
- $92.20m
- 73
- 23
- 91
- 66
Annual income statement for Allot, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 136 | 146 | 123 | 93.2 | 92.2 |
| Cost of Revenue | |||||
| Gross Profit | 95.8 | 101 | 82.9 | 52.7 | 63.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 145 | 159 | 155 | 158 | 98.2 |
| Operating Profit | -9.03 | -13.5 | -32.3 | -64.9 | -6.01 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.17 | -13.2 | -30.1 | -61.7 | -4.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -9.35 | -15 | -32 | -62.8 | -5.87 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -9.35 | -15 | -32 | -62.8 | -5.87 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.35 | -15 | -32 | -62.8 | -5.87 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.164 | -0.29 | -0.789 | -1.53 | -0.069 |